KEEP UP WITH THE LATEST IN INDUSTRY NEWS!
From news about new medicines, pharmacy business insights, and the pharmaceutical industry in general—this is your source!
DrugTopics articles
- CBT, Rehabilitation May Improve Symptoms of Long COVID December 2, 2024A recent study showed that cognitive behavioral therapy could help reduce fatigue and improve concentration with moderate certainty.
- Cannabis Could Help Reduce Opioid Use in Patients with Chronic Pain December 2, 2024Most patients with reduced opioid prescriptions during cannabis use had chronic musculoskeletal pain.
- Influenza Vaccine Least Effective for Children Facing Secondary Infection December 2, 2024Researchers addressed vaccine effectiveness for individuals with direct household contacts that reported influenza.
- Q&A: How HIV Care Has Allowed Pharmacists to Practice at the Top of Their Licenses December 1, 2024Jay Holloway, PharmD, AAHIVP, Pharmacist with the AIDS Healthcare Foundation, joined Drug Topics to discuss the role pharmacists play in providing care for people with HIV.
- Drug Topics Top 10: Most Read Stories From November 2024 December 1, 2024Check out this list of our top 10 stories from November 2024.
- Nonopioid Pain Management Roundup: Osteoarthritis Treatments, Chronic Pain in Veterans November 30, 2024Catch up on important nonopioid pain management news from November 2024.
- Q&A: The Future of Biosimilar Pricing at the Pharmacy Counter November 30, 2024Steve Callahan, Senior Director of Advisory & Insights at MMIT, discussed out-of-pocket costs and the impact biosimilars are predicted to have for patients in the future.
- Q&A: Pharmacist on Medication Developments for People Living with HIV November 29, 2024Jay Holloway, PharmD, AAHIVP, Pharmacist with the AIDS Healthcare Foundation, discussed the ongoing developments impacting patients with HIV and their prescription drugs.
- COVID-19 Roundup: Importance of Vaccine Uptake in Winter, Obesity’s Link with Long COVID November 29, 2024Catch up on important COVID-19 news from November 2024.
- Q&A: A Closer Look at the Current State of Biosimilars in the Drug Market November 28, 2024Steve Callahan, Senior Director of Advisory & Insights at MMIT, sat down with Drug Topics to discuss industry trends behind biosimilars.
Pharmacy Times articles
- From Dogs to Humans: AI-Powered Drug Response Prediction Technology Demonstrates Improved Clinical Outcomes in Oncology December 2, 2024AI-powered drug response prediction technology is revolutionizing veterinary and human oncology by enabling personalized treatment plans through live cell testing, machine learning models, and data-driven precision medicine approaches.
- Camber Pharmaceuticals Introduces Lidocaine HCI Injection, USP, in Single- and Multi-Dose Vials December 2, 2024Featuring 1% and 2% concentrations, this versatile product is available in various vial and pack sizes to meet diverse healthcare needs.
- Before the Big Event: AI-Enabled Remote Cardiac Monitoring Can Mitigate Stress-Related Cardiovascular Events December 2, 2024AI-enabled remote cardiac telemetry can help manage stress’s effects on high-risk populations.
- Monitoring Serum Magnesium Levels Helps Manage Hypomagnesemia for Patients With Type 2 Diabetes December 2, 2024The pharmacist’s role includes determining if there are any medications that are contributing to magnesium deficiency for patients with diabetes who are at an increased risk.
- Data Further Confirm Proposed Denosumab Biosimilar Shows Similar Efficacy to Originator December 2, 2024Investigators presented additional data from a clinical trial at the American College of Rheumatology Convergence, demonstrating similar safety for postmenopausal women with osteoporosis.
- Looming PREP Act Expiration Could Impact Health Care Access for Rural Patients December 2, 2024The Act is set to end at the end of 2024, which will affect pharmacists’ abilities to administer COVID-19 tests, vaccines, and treatment that are distributed by the federal government.
- Photoacoustic Breast Imaging Can Reduce Skin Tone Biases While Detecting Cancer Early December 2, 2024When different skin tones are considered in imaging systems, women will receive more equitable screening and care.
- Zerlasiran Shows Significant Lipoprotein(a) Reduction in Phase 2 Trial December 2, 2024Lipoprotein(a) is a known risk factor for atherosclerotic cardiovascular disease.
- Patients With Anemia and Myelofibrosis Have Worse Survival Outcomes When Treated With Ruxolitinib December 2, 2024Anemia is a common adverse effect of ruxolitinib, calling for new approaches to mitigate risks.
- Study Finds Associations Between Memory Difficulties and History of Asthma in Children December 2, 2024Asthma onset earlier in childhood may be linked to more severe difficulties that could extend to executive function abilities.
Helping You Navigate the Returns Process!
Pedigree Statement
Flash Returns, LLC has strict standard operating procedures and a pharmaceutical services agreement (PSA) with it’s clients…
Flash Returns, LLC has strict standard operating procedures and a pharmaceutical services agreement (PSA) with its clients. This is to ensure that the reverse distribution portion of the supply chain that we service keeps its functionality and integrity for our customers and the public.
Several pedigree and distribution level issues have been raised in the industry. Discounted, indigent-pricing, short dated, bulk purchase, secondary distribution, or DSCSA non-compliant sales could affect the credit available for a product based on a manufacturers determination. We ask that you do not return these products for credit as they are not eligible in most cases. Flash Returns LLC may choose to dispose of these on the pharmacies behalf at no charge if the cost is low relative to the return. Most customers purchasing products from reputable wholesalers will not encounter these issues, however all pharmacies are asked to acknowledge our policy on pedigree and legitimacy of product here and by signing the PSA before a return is initiated.
Some manufacturers may require proof the price paid for a product and what wholesaler distributed the product. Issues causing triggering this could be: bulk or large quantities of single items or lots, or products purchased speculatively. In some cases we may request invoices from the customer to ensure Flash Returns or manufacturer policy is being met. If none are available or if the information isn’t accepted by the manufacturer it could cause the return to be non-returnable.
Flash Returns, LLC cannot guarantee or be liable for the value or credit for products that were purchased outside of manufacturer accepted distribution channels. This could include products: purchased from a wholesaler that is not an approved vendor, products not purchased directly from a particular manufacturer, purchased on a speculative basis, diverted or counterfeit products, foreign products, and any product purchased on a non-returnable basis, including short-dated product purchased at discounted pricing.
At any time, Flash Returns, LLC or a manufacturer may require invoices or pedigree information demonstrating proof of purchase. If product has been shipped by Flash Returns, LLC or the Customer to a manufacturer or their agent, Flash Returns, LLC cannot guarantee or facilitate the return of product to the Customer. Manufacturers reverse the right to destroy product they deem not credit worthy or suspect. Manufacturers agreeing to return product to customers will do so at the customers expense. Flash Returns, LLC shall not be responsible for reimbursing a Customer for such product.
If Customer is unable to have product returned within 21 days, product is subject to be destroyed without any payment or credit issued to Customer. In any dispute, failure by Customer to provide invoices for a product or pedigree if requested shall release Flash Returns, LLC from any and all liability of products involved in dispute including the full value of the product. More information on drug pedigrees is available on the FDA website at:
Pedigree Statement
P: 833.553.5274
E: SignUp@FlashReturns.com